| 001 | 136729 | ||
| 005 | 20240321220126.0 | ||
| 024 | 7 | _ | |a 10.1159/000342907 |2 doi |
| 024 | 7 | _ | |a pmid:23146840 |2 pmid |
| 024 | 7 | _ | |a 0014-3022 |2 ISSN |
| 024 | 7 | _ | |a 1421-9913 |2 ISSN |
| 037 | _ | _ | |a DZNE-2020-03051 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Fonteyn, E. M. R. |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a Prospective analysis of falls in dominant ataxias. |
| 260 | _ | _ | |a Basel |c 2013 |b Karger |
| 264 | _ | 1 | |3 print |2 Crossref |b S. Karger AG |c 2013-01-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1585579460_26569 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a In a previous retrospective study, we demonstrated that falls are common and often injurious in dominant spinocerebellar ataxias (SCAs) and that nonataxia features play an important role in these falls. Retrospective surveys are plagued by recall bias for the presence and details of prior falls. We therefore sought to corroborate and extend these retrospective findings by means of a prospective extension of this fall study. 113 patients with SCA1, SCA2, SCA3 or SCA6, recruited from the EuroSCA natural history study, were asked to keep a fall diary in between their annual visits to the participating centres. Additionally, patients completed a detailed questionnaire about the first three falls, to identify specific fall circumstances. Relevant disease characteristics were retrieved from the EuroSCA registry. 84.1% of patients reported at least one fall during a time period of 12 months. Fall-related injuries were common and their frequency increased with that of falls. The presence of nonataxia symptoms was associated with a higher fall frequency. This study confirms that falls are a frequent and serious complication of SCA, and that the presence of nonataxia symptoms is an important etiological factor in its occurrence. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 536 | _ | _ | |a 345 - Population Studies and Genetics (POF3-345) |0 G:(DE-HGF)POF3-345 |c POF3-345 |f POF III |x 1 |
| 542 | _ | _ | |i 2013-01-01 |2 Crossref |u https://www.karger.com/Services/SiteLicenses |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 2 | |a Accidental Falls: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Adult |2 MeSH |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Aged, 80 and over |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Longitudinal Studies |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Prevalence |2 MeSH |
| 650 | _ | 2 | |a Prospective Studies |2 MeSH |
| 650 | _ | 2 | |a Spinocerebellar Ataxias: complications |2 MeSH |
| 650 | _ | 2 | |a Spinocerebellar Ataxias: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Spinocerebellar Ataxias: genetics |2 MeSH |
| 700 | 1 | _ | |a Schmitz-Hübsch, T. |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Verstappen, C. C. P. |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Baliko, L. |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Bloem, B. R. |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Boesch, S. |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Bunn, L. |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Giunti, P. |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Globas, C. |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Klockgether, T. |0 P:(DE-2719)2810314 |b 9 |u dzne |
| 700 | 1 | _ | |a Melegh, B. |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Pandolfo, M. |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Schöls, L. |0 P:(DE-2719)2810795 |b 12 |u dzne |
| 700 | 1 | _ | |a Timmann, D. |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a van de Warrenburg, B. P. C. |0 P:(DE-HGF)0 |b 14 |e Corresponding author |
| 773 | 1 | 8 | |a 10.1159/000342907 |b : S. Karger AG, 2013-01-01 |n 1 |p 53-57 |3 journal-article |2 Crossref |t European Neurology |v 69 |y 2013 |x 1421-9913 |
| 773 | _ | _ | |a 10.1159/000342907 |g Vol. 69, no. 1, p. 53 - 57 |0 PERI:(DE-600)1482237-4 |n 1 |q 69:1<53 - 57 |p 53-57 |t European neurology |v 69 |y 2013 |x 1421-9913 |
| 909 | C | O | |o oai:pub.dzne.de:136729 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2810314 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2810795 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |2 G:(DE-HGF)POF3-300 |v Clinical and Health Care Research |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |2 G:(DE-HGF)POF3-300 |v Population Studies and Genetics |x 1 |
| 914 | 1 | _ | |y 2013 |
| 915 | _ | _ | |a Allianz-Lizenz |0 StatID:(DE-HGF)0410 |2 StatID |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR NEUROL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-2719)5000005 |k AG Schöls 1 |l Clinical Neurogenetics |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1011101 |k Patient studies, Bonn |l Patient studies |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)5000005 |
| 980 | _ | _ | |a I:(DE-2719)1011101 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1016/S1474-4422(10)70183-6 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1474-4422(10)70183-6 |
| 999 | C | 5 | |a 10.1007/s12311-010-0155-z |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s12311-010-0155-z |
| 999 | C | 5 | |a 10.1212/WNL.0b013e31822e7ca0 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0b013e31822e7ca0 |
| 999 | C | 5 | |a 10.1212/01.wnl.0000219042.60538.92 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/01.wnl.0000219042.60538.92 |
| 999 | C | 5 | |a 10.1212/01.wnl.0000325057.33666.72 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/01.wnl.0000325057.33666.72 |
| 999 | C | 5 | |a 10.1007/s004150170047 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s004150170047 |
| 999 | C | 5 | |a 10.1002/mds.20375 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.20375 |
| 999 | C | 5 | |a 10.1111/j.1532-5415.2010.03263.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1532-5415.2010.03263.x |
| 999 | C | 5 | |a 10.1212/WNL.0b013e3181c33adf |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0b013e3181c33adf |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|